KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Change in Receivables (2016 - 2025)

Biogen has reported Change in Receivables over the past 17 years, most recently at -$114.5 million for Q4 2025.

  • Quarterly results put Change in Receivables at -$114.5 million for Q4 2025, up 51.93% from a year ago — trailing twelve months through Dec 2025 was -$102.7 million (up 53.8% YoY), and the annual figure for FY2025 was -$102.7 million, up 53.8%.
  • Change in Receivables for Q4 2025 was -$114.5 million at Biogen, up from -$158.7 million in the prior quarter.
  • Over the last five years, Change in Receivables for BIIB hit a ceiling of $181.0 million in Q1 2025 and a floor of -$238.2 million in Q4 2024.
  • Median Change in Receivables over the past 5 years was -$23.8 million (2021), compared with a mean of -$25.4 million.
  • Biggest five-year swings in Change in Receivables: crashed 673.36% in 2021 and later soared 514.19% in 2025.
  • Biogen's Change in Receivables stood at -$167.0 million in 2021, then skyrocketed by 156.23% to $93.9 million in 2022, then crashed by 246.75% to -$137.8 million in 2023, then tumbled by 72.86% to -$238.2 million in 2024, then soared by 51.93% to -$114.5 million in 2025.
  • The last three reported values for Change in Receivables were -$114.5 million (Q4 2025), -$158.7 million (Q3 2025), and -$10.5 million (Q2 2025) per Business Quant data.